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One factor in the development of neuroAIDS is the increase in the migration of pro-
inflammatory CD8 T cells across the blood–brain barrier. Typically these cells are
involved with keeping the viral load down. However, the persistence of above average
numbers of CD8 T cells in the brain, not necessarily specific to viral peptides, is
facilitated by the upregulation of IL15 from astrocytes, in the absence of IL2, in the brain
environment. Both IL15 and IL2 are common gamma chain (γc) cytokines. Here, using
the non-human primate model of neuroAIDS, we have demonstrated that exposure to
methamphetamine, a powerful illicit drug that has been associated with HIV exposure
and neuroAIDS severity, can cause an increase in molecules of the γc system. Among
these molecules, IL15, which is upregulated in astrocytes by methamphetamine, and
that induces the proliferation of T cells, may also be involved in driving an inflammatory
phenotype in innate immune cells of the brain. Therefore, methamphetamine and
IL15 may be critical in the development and aggravation of central nervous system
immune-mediated inflammatory pathology in HIV-infected drug abusers.
Keywords: gamma-chain cytokines, SIV, HIV infections, NeuroAIDS, methamphetamine, IL15, macrophages,
microglia
Introduction
The immunological environment of the central nervous system (CNS) is highly susceptible to
changes due to a number of insults, such as infections that cross the blood–brain barrier (BBB),
or even related peripheral changes. In the case of infections with HIV in humans, or simian
immunodeﬁciency virus (SIV) in macaques, the viruses are able to reach the brain very early. As
a consequence, glial activation and the development of a pro-inﬂammatory cytokine environment
favor the accumulation of activated CD8 T cells and macrophages (Marcondes et al., 2001, 2007).
These changes in the brain are associated to the development of deﬁcits in motor and cognitive
abilities, and other disruptions such as in the circadian rhythm of body temperature and sleep
patterns (Marcondes et al., 2001; Huitron-Resendiz et al., 2007).
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Drugs of abuse can also alter the levels of inﬂammatory factors
in the brain. Methamphetamine (Meth), for instance, which
is an illegal psycho-stimulant abused at epidemic proportions
in USA and worldwide (Mathers et al., 2008) can exacerbate
inﬂammation in the CNS (Mathers et al., 2008). Furthermore,
a large number of HIV-infected individuals acquire the virus
from Meth use or are exposed to this drug during disease
course (Mathers et al., 2008). Both HIV infection and Meth
dependence can be associated with brain dysfunction. In fact,
viral burden in the brain and inﬂammatory neuropathology
associated with HIV infection are drastically aggravated by Meth
use (Everall et al., 2005), which contributes to the severity of
neuroAIDS.
In an experimental model of Meth-abuse in simian
immunodeﬁciency virus (SIV)-infected macaques, we
have previously found that Meth treatment aggravated the
inﬂammatory pathology and increased viral load in the brain
(Marcondes et al., 2010). We have also shown that one of the
factors involved in the overall development of neuroAIDS is an
increase, of up to 10-fold, in the migration of pro-inﬂammatory
CD8 T cells (Marcondes et al., 2001). Importantly, speciﬁc CD8
T cells in the brain tissue keep viral load down (Marcondes
et al., 2015). However, the persistence of CD8 T cells that are
not necessarily speciﬁc to viral peptides is facilitated by the
upregulation of IL15 in astrocytes, and an absence of IL2, both
of which are common gamma chain (γc) cytokines (Marcondes
et al., 2007). How the expression of IL15 and other cytokines of
the common γc family are aﬀected by Meth, and whether they
can contribute to the enhanced pathology caused by the drug in
the brain, have never been addressed.
The common gamma chain (γc; CD132), also known as
interleukin-2 receptor gamma subunit or IL-2RG, is a cytokine
receptor sub-unit common to receptor complexes for diﬀerent
interleukin receptors, including IL-2, IL-4, IL-7, IL-9, and IL-15.
Each one of these cytokines use additional subunits that provide
signaling and function speciﬁcity (Fehniger and Caligiuri, 2001).
These cytokines play a role in both the innate and adaptive
immune responses. The fact that these cytokines share γc binding
provides a basis for some of their redundant actions. However,
γc-cytokines may also compete for opposing eﬀects based on
their binding to other potential receptors. For instance, IL-7
regulates survival of immature and mature T lymphocytes, while
IL-2, IL-15, and IL-21 appear to have speciﬁc functions in T
cell homeostasis and memory diﬀerentiation; on the other hand,
the balance between IL2 and IL15 deeply aﬀects T cell survival
(Marrack et al., 1998; Vella et al., 1998; Boyman et al., 2007;
Mitchell et al., 2010). Memory CD8 T cells can utilize either IL-
7 or IL-15 to undergo Ag-independent homeostatic proliferation
and activation (Tan et al., 2002). Conversely, HIV gag-speciﬁc T
cells show enhanced Ag-speciﬁc IFN-γ responses upon exposure
to IL-2, IL-15, or combined IL-15/IL-7, suggesting that these
cytokines are able to rescue activation in speciﬁc cells (Gu et al.,
2007), as well as in cells with other speciﬁcities.
The eﬀects of γc-cytokines in cells of the innate immune
system are not well-known. Interestingly, γc-cytokines, especially
IL15, aﬀect the development and function of NK cells (Kawamura
et al., 2003). It is also known that IL15 induces proliferation of
innate immune cells, and signals via IL-15Rα, JNK, and NF-κB
to drive RANTES production by myeloid cells (Chenoweth
et al., 2012). In human monocytes, IL-15 induces IL-8 and
MCP-1 production, which further attract inﬂammatory cells
to expression sites (Badolato et al., 1997). In addition, the
interaction of IL-15-IL-15R is critical in early activation of
antigen-presenting cells and plays an important role in the innate
immune system (Ohteki et al., 2001). In macrophages, IL-15 also
functions as a potent autocrine regulator of proinﬂammatory
cytokine production by these cells, with high concentrations of
IL-15 favoring TNF-α, IL-1, and IL-6 production, and very low
concentrations of IL-15 favoring IL-10 production (Alleva et al.,
1997).
Here, we investigated the expression of γc-cytokines and
receptors in isolated mononuclear cells from the brains of SIV-
infected macaques, treated or not with Meth, in an eﬀort to
explain the development of a pro-inﬂammatory environment and
high NK activation. We also examined the ability of IL15 to
induce an innate immune phenotype that mimics the one found
in Meth use. Our results suggest a role for IL15 and the common
gamma chain system in the inﬂammatory pathogenesis of SIV,
which is aggravated by Meth in the CNS.
Materials and Methods
Monkeys and SIV Infection
SIV, SRV-type D, and Herpes B Virus-free rhesus macaques
of Chinese origin purchased from Valley Biosystems (West
Sacramento, CA, USA), were infected with a cell-free SIV
stock derived from SIVmac251 (Lane et al., 1995; Watry et al.,
1995). All animal experiments were performed with approval
from the Institutional Animal Care and Use Committee and
followed NIH guidelines. Animals kept in containment were
anesthetized with 10–15 mg/kg of ketamine intramuscularly
prior to experimental procedures. Blood was serially drawn
from the femoral vein, and plasma was obtained from EDTA-
treated blood. At necropsy, which was performed after terminal
anesthesia, animals were intracardially perfused with sterile PBS
containing 1 U/ml heparin. Tissue samples were taken for cell
isolation, virus quantiﬁcation, and formalin ﬁxation for histology.
Meth Treatment and Design
At 19 weeks pi, when plasma viral load averaged 5.3 (log10),
three out of seven infected animals were started on an escalating
protocol of Meth administration. Importantly, we mimicked
the amount of Meth used by chronic abusers with our drug
administration schedule. Matching uninfected controls were also
included. Human chronic Meth abusers, who generally increase
their dosage over time, reach up to 1 g/day. In a recent high-
resolution MRI study demonstrating Meth-induced defects in
human brains, subjects averaged 3.4 g/week of Meth (Thompson
et al., 2004). Assuming an average of 70 kg body weight and 50%
purity of the Meth (the average according to US Department
of Justice statistics), this averages to ∼24–25 mg/kg/week. Since
a typical abuser takes Meth 1–3 times a day for more than
20 days a month (Simon et al., 2002), we used a modiﬁcation
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of our escalating dose regimen, giving Meth for 5 days a week,
twice a day, at a dose of 2.5 mg/kg. After a 5 weeks ramp-
up, ﬁnal total dosage was 25 mg/kg/week, approximating the
amounts used by chronic Meth abusers. This level was then
maintained for an additional 18 weeks. The four uninfected
control animals, and four SIV-infected animals, received PBS
injections on the same schedule. All animals were sacriﬁced at
42 weeks pi.
Mononuclear Cells
The macaque brain was removed at necropsy following
intravascular perfusion. For isolation of cells from the brain, the
brain was carefully freed of meninges. Brain mononuclear cells
were isolated by enzymatic digestion of minced tissue, followed
by Percoll (Sigma-Aldrich) gradient, as previously described
(Marcondes et al., 2001). Cell pellets were either stained with
antibodies for ﬂow cytometry or snap frozen and maintained in
liquid nitrogen prior to mRNA extraction either for gene array or
for real time PCR.
Flow Cytometry
Percoll-isolated mononuclear cells from macaque brains as well
as THP1 macrophages from cell culture (see below) were washed
in PBS containing 2% FCS and 0.01% NaN3, and characterized
by staining with labeled antibodies, using BD Cytoﬁx/Cytoperm
solution kit (BDPharmingen, San Jose, CA,USA), For cell surface
phenotyping and proliferation, the antibodies used were: PE-
labeled anti-CD11b clone M1/70 (Biolegend, San Diego, CA,
USA), APC-labeled anti-human CD195 (CCR5), clone J418F1
(Biolegend), PeCy7-labeled anti-human CD11a clone 25.3.1
(Beckman Coulter, Brea, CA, USA), and FITC-labeled anti-Ki67
clone MIB-1 (Dako, Carpinteria, CA, USA). Stained cells were
acquired by a FACSCalibur (BD Biosciences, San Jose, CA, USA)
ﬂow cytometer, and analyzed in FlowJo 6.2.1 software (Tree Star,
Inc., San Carlos, CA, USA).
Gene Arrays and Pathway Analysis
Gene analysis was performed by Miltenyi Biotec. All samples
were individually performed in duplicate. RNA was isolated
from 17 macaques using standard RNA extraction protocols
(NucleoSpin RNA II, Macherey-Nagel). Quality of the samples
was checked via Agilent 2100 Bioanalyzer platform (Agilent
technologies). A RNA integrity number (RIN) was calculated by
a proprietary algorithm that takes several QC parameters into
account, such as 28S/18S RNA peak area ratios and unexpected
peaks in the 5S RNA region, and RIN number of 10 indicates
high quality, and 1 low quality. A RIN >6 is of suﬃcient quality
for gene expression proﬁling experiments (Fleige and Pfaﬄ,
2006; Fleige et al., 2006). All samples, except for one animal
(492 – Normal control) showed values above 6. That animal was
excluded from the analysis, leaving the healthy control group
with an n = 4. For the linear T7-based ampliﬁcation step,
100 ng of each total RNA sample was used. To produce Cy3-
labeled cRNA, the RNA samples were ampliﬁed and labeled
using the Agilent Low Input Quick Amp Labeling kit (Agilent
Technologies) following the manufacturer’s protocol. Yields of
cRNA and the dye incorporation rate were measured with
the ND-1000 spectrophotometer (Nanodrop Technologies). The
hybridization procedure was performed according to Agilent
60-mer Oligo microarray processing protocol using the Agilent
gene expression hybridization kit (Agilent Technologies). Brieﬂy,
1.65 ug Cy3-labeled fragmented cRNA in hybridization buﬀer
was hybridized overnight (17 h, 65◦C) to Agilent Whole Rhesus
monkey Genome oligo microarrays 4x44K (one-color) using
Agilent’s recommended hybridization chamber and oven. Finally,
the microarrays were washed once with the Agilent Gene
expression wash buﬀer 1 for 1 min at room temperature,
followed by a second wash with pre-heated Agilent Gene
expression wash buﬀer 2 (37◦C) for 1 min. The last washing
step was performed with acetonitrile. Fluorescent signals of the
hybridized microarrays were detected using Agilent’s microarray
Scanner System (Agilent Technologies). The Agilent Feature
extraction software (FES) was used to read out and process
the microarray image ﬁles. The software determines feature
intensities (including background subtraction), rejects outliers
and calculates statistical conﬁdences. For determination of
diﬀerential gene expression, FES derived output data ﬁles
were further analyzed using Rosetta Resolver gene expression
data analysis system (Rosetta Biosoftware). This software oﬀers
the possibility to compare two single intensity proﬁles in a
ratio experiment. Output data were normalized by dividing
their intensity values by the median. These normalized signal
intensities were joined to a common table with the entire
normalized experiment data list. Fold change, sample/control
log10 ratios, and p values were analyzed with Resolver
software. The complete expression dataset was then mapped
and groups were compared using an integrative systems
biology approach. To complete the bioinformatics analysis,
two knowledge base resources were queried: the Ingenuity
Knowledge Base (Calvano et al., 2005) and an interaction
repository, which is based on cpath (Cerami et al., 2006,
2011; Cline et al., 2007), and includes interactions curated by
GeneGo (http://www.genego.com) and Ingenuity. We focused
on brain-derived mononuclear cells to compare between Meth
and Control and between SIV/Meth and SIV, to select for high
score gene nodes, ﬁltered for a minimum of three genes showing
similar behavior.
Real Time PCR
First Strand kit (Qiagen) was used for cDNA synthesis. Primers in
Table 1 were designed based on available sequences for Macaca
mulatta in Gene Database for detection of relative levels using
SyBrGreen/ROX in an ABI HT7900 machine. Data was analyzed
with Sequence Detection System software and normalized with
GAPDH expression.
Immunohistochemistry
Macaque tissue was ﬁxed in 10% formalin and paraﬃn
embedded. Five μm sections were stained with hematoxylin
and eosin and examined microscopically. Indirect
immunohistochemical staining for IL15 (R&D Systems), NOS2
(Cayman Chemical, Ann Arbor, MI, USA), IL6 and CD163
(both Novus Biologicals, Litleton, CO, USA), were performed
as previously described (Roberts et al., 2003; Marcondes et al.,
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TABLE 1 | Macaque primer sequences.
Forward 5′ Reverse 3′
rhIL2 gtcacaaacagtgcacctac atggttgctgtctcatcagc
rhIL4 tgcctccaagaacacaactg aacgtactctggttggcttc
rhIL7 cgcaagttgaggcaatttct ctttgttggttggggttcac
rhIL21 tcgccacatgattagaatgc gcacctgtggaaggtgattt
rhIL2RG gtcagtgagattcccccaaa atggggacacaaaattccaa
rhITK tctgggaattagccccttct taggcattctcgtgcctctt
rhIL7R gcgtatgtcaccatgtccag aggatgctcttgcctcatgt
rhIL15RA gatgccttccacatcgtctt ttgatgtagcatgccaggag
rhIL21R cgtggtgtccatcgatacag gggtggctttagtctgtcca
rhNOS2 acacctcaccacaaggccaa ctggggaacaagacaggcat
rhIL6 ccagccactgacctcttcag gagatgcgtcgtcatctcct
rhMrc1 caccaaaacctgagccaacg ggcccaagacacgtaatcca
rhCD163 gcaggttctggacgcatttg acacactgttccccactgtc
rhArg1 ttggcttgagagacgtggac gagcaactccaaagcaagcc
rhStat6 ttgaactcgctggacagagc aagtcgacatagagccgctg
2007). Colorimetric development was performed with the
NovaRed chromagen (Vector) followed by a hematoxylin
counterstain (Sigma-Aldrich).
THP1 Cell Culture and Stimulation
THP1 cells were maintained in our lab, in suspension, in
cell culture ﬂasks (Costar, Cambridge, MA, USA) at a density
of 2.5 × 105 cells/ml to 1.0 × 106 cells/ml in RPMI-1640
with GlutaMAX containing 10% fetal calf serum (Invitrogen,
Carlsbad, CA, USA), 10 mM HEPES (Invitrogen), and Pen-Strep
(Invitrogen). Cells were plated at 1 × 106 cell/ml in 24 well
ﬂat-bottomed plates (Costar) and treated with the cytokines IL4
(10 U/ml), IL7 (10 U/ml), IL15 (50 U/ml), or with the control
IFNb (0.5 ng/ml) for 48 h (R&D Systems, Minneapolis, MN,
USA). Cell viability following treatments was conﬁrmed using
Trypan Blue (Invitrogen) exclusion test. RNA extraction after
treatments was completed using the RNeasy Mini Kit (Qiagen),
followed by First Strand kit (Qiagen) for cDNA synthesis.
Primers in Table 2 were based on available sequences for Homo
sapiens in Gene Database for detection of relative levels using
SyBrGreen/ROX in an ABI HT7900 machine. Data was analyzed
with Sequence Detection System software and normalized with
GAPDH expression.
TABLE 2 | Human primer sequences.
Forward 5′ Reverse 3′
HuNOS2 gtggaagcggtaacaaagga tgccattgttggtggagtaa
HuTNFa cagagggcctgtacctcatc ggaagacccctcccagatag
HuIL6 agtgcctctttgctgctttcac tgacaaacaaattcggtacatcct
HuArg1 cctttctcaaagggacagcca gatgggtccagtccgtcaaca
HuMrc1 ggcggtgacctcacaagtat ttttcatggcttggttctcc
HuCD163 ttgccagcagttaaatgtg aggacagtgtttgggactgg
HuTGFb ctgctgaggctcaagttaaaagtg tgaggtatcgccaggaattgtt
HuStat6 ctgccaaagacctgtccatt ggtaggcatctggagctctg
HuIL10 gccgtggagcaggtgaag tggctttgtagatgcctttctct
Statistical Analysis
Group comparisons for individual genes across conditions were
performed using one way ANOVA, followed by Bonferroni’s
post hoc tests. The diﬀerence between the means was considered
signiﬁcant at p < 0.05. Tests were performed using Prism
software (GraphPad Software, San Diego, CA, USA) for
Macintosh.
Results
Expression of Molecules of the IL2RG System
are Modified by Meth In Vivo
Immune cells isolated from macaque’s brains were highly
enriched for CD11b expression (>89%), therefore mostly
comprised of microglia and brain resident and inﬁltrating
macrophages, 0.5–7% CD3+CD8+ T lymphocytes and <2%
CD3–CD8+ NK cells, as previously described. These cells,
denominated brain mononuclear cells, were characterized
regarding changes in gene expression caused by SIV infection,
Meth, or the interaction between SIV andMeth. Using gene array
on the isolated mononuclear cells, followed by a systems biology
analysis approach, we focused on genes that were upregulated
both in the SIV-only and in Meth-only groups, compared to
controls, and that were also upregulated in the SIV/Meth group
compared to SIV-only group. We found that the expression of
IL2RG, used by all common gamma chain cytokines, exhibited
a highly signiﬁcant upregulation pattern in SIV compared to
control (p = 0.000045), and in SIV/Meth compared to SIV
(p = 0.0001). In terms of fold change, IL2RG was among
the 50 genes most upregulated by Meth alone, compared to
controls (2.06-fold, p = 0.001). Further investigation of the gene
cluster associated to the IL2RG gene was further analyzed, given
their important role for the development of an inﬂammatory
millieu. Of the cytokines that utilize the common gamma-
chain, the expression of IL4 and IL15 was signiﬁcantly enhanced
by Meth (Table 3). On the other hand, and consistent with
previous ﬁndings upon SIV infection (Marcondes et al., 2007), the
expression of IL2 was not signiﬁcantly increased by Meth either
alone or in SIV-infected macaques (Table 3). The IL15RA, which
binds IL15 with high aﬃnity, was also upregulated by Meth, but
not by SIV alone (Table 3). Together, these ﬁndings suggest that
the molecules in the IL2RG cytokine system may are aﬀected by
Meth, and may play a role on the eﬀects of the drug in the context
of SIV infection in the brain.
We further conﬁrmed changes in the expression of IL2RG,
co-receptors and ligands involved in this system by using SyBr
Green – qRT-PCR (Figure 1). Together, the expression of
molecules in the IL2RG system showed equal variance (Bartlett’s
p < 0.0001), and there was a signiﬁcant diﬀerence between
all groups (two-way ANOVA p = 0.013, p < 0.0001 for the
eﬀect of treatments, p < 0.0001 for the eﬀect of genes, and
p < 0.0001 for the eﬀect of interaction). Individually, Meth only
and SIV only caused diﬀerences in the transcriptional levels of
these molecules. For instance, conﬁrming our previous ﬁndings
(Marcondes et al., 2007), IL15 was upregulated in the brain by
SIV infection, and was further increased by Meth in SIV-infected
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TABLE 3 | Fold change and statistical behavior of common yc family molecules and related signaling components from gene profiling of isolated
microglia and brain mononuclear cells.
Gene name Fold change Meth/Ctr p-value Meth/Ctr Fold change SIV/Ctr p-value SIV/Ctr Fold change SIVMeth/SIV p-value SIVMeth/SIV
IL2 1.13 0.76 0.54 0.13 2.17 0.41
IL4 2.58 0.016 1.38 0.19 15.49 0.03
IL7 1.11 0.72 1.31 0.32 6.89 0.19
IL7R 1.72 0.12 1.64 0.23 5.3 0.049
IL9R 0.73 0.30 0.79 0.28 1.56 0.32
IL15 1.21 0.35 2.01 0.026 4.73 0.04
IL15RA 1.84 0.05 3.82 0.05 2.43 0.05
IL21 1.04 0.91 0.5 0.01 1.53 0.35
IL21R 0.98 0.91 4.16 0.19 2.76 0.18
IL2RG 2.06 0.001 4.49 0.00005 6.71 0.0001
ITK 1.00 0.99 1.33 0.53 11.8 0.026
Values in bold are statistically significant.
FIGURE 1 | Transcriptional levels of (A) IL15 and IL15RA, (B) IL21 and IL21R, (C) IL7 and IL7R, and (D) IL2, IL2RG and ITK. Transcriptional expression of
common gamma chain pathway components in isolated immune cells from the brain of rhesus macaques infected with SIV and treated with Meth. Results are
expressed as average ± SEM of three technical replicates, with results normalized to the expression of GAPDH. ∗p ≤ 0.05 in comparisons shown in lines (one-way
ANOVA p-value is reported in Results, and was followed by Bonferroni’s post hoc test).
macaques (ANOVA p = 0.0069; Figure 1A). Furthermore, the
expression of IL15RA was signiﬁcantly increased both by SIV
infection and by SIV/Meth, compared to uninfected controls and
to Meth-only controls (ANOVA p = 0.0001; Figure 1A).
The expression of IL21 was signiﬁcantly decreased by SIV
infection, but this expression did not diﬀer between SIV/Meth
and baseline (ANOVA p = 0.0001; Figure 1B). On the other
hand, the levels of the IL21R were increased both by SIV and
SIV/Meth, but no additive eﬀect was observed (Figure 1B).
The expression of IL7 and IL7R in the brain was not altered
either by Meth alone or by SIV alone. However, in Meth-treated
SIV-infected animals, both IL7 and IL7R were signiﬁcantly
increased compared to controls (ANOVA p = 0.0122 and
p< 0.0001, respectively; Figure 1C).
Conﬁrming our previous ﬁndings in SIV-infected brains
(Marcondes et al., 2007), IL2 expression was decreased by SIV
infection. Interestingly, neither the Meth alone group nor the
SIV/Meth group had IL2 levels that diﬀered from baseline
(ANOVA p = 0.049; Figure 1D). However, we conﬁrmed the
signiﬁcant upregulation of IL2RG both by Meth and by SIV,
and a signiﬁcant additive eﬀect in SIV/Meth animals (ANOVA
p = 0.008; Figure 1D). Conversely, we also conﬁrmed that
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the expression of ITK was increased in the brain of SIV/Meth
animals, but not in Meth or SIV-only groups when compared to
controls (ANOVA p = 0.012; Figure 1D).
By qRT-PCR, IL4 expression was not aﬀected by Meth or SIV,
but it was signiﬁcantly upregulated in SIV/Meth animals (5.3-
fold) compared to controls or to SIV alone (not shown, ANOVA
p= 0.0157, Bonferroni p= 0.05 and p= 0.043, respectively). The
expression of the IL4R was not detectable in brain mononuclear
cells.
Together, these data validate our systems approach, and
suggest that Meth can further enhance the levels of cytokines and
receptors in the IL2RG pathway, both alone and in the context of
SIV infection. Among these molecules, IL15 and IL15RA were
signiﬁcantly upregulated in the context of SIV, and were also
further upregulated by Meth. Thus, we examined a potential role
for IL15 in modifying inﬂammatory characteristics associated
to pathogenesis. We investigated IL15 tissue localization using
immunohistochemistry and detected an important increase at
the protein level. Figure 2 shows the staining pattern of IL15
on frontal cortex sections from SIV and SIV/Meth macaques
(Figures 2A,B, respectively). The staining was predominantly
associated with endothelial cells, astrocytes, and inﬁltrating cells
(see arrows and legend). The increase in IL15 and in the
number of IL15-expressing cells caused by Meth appeared to be
mainly associated to astrocytes, but also to a higher number of
inﬁltrating mononuclear cells with morphological characteristics
of macrophages (Figure 2B).
IL2RG – Binding Cytokines Increase
Macrophage Proliferation
We have previously shown that the increase in IL15, which
is involved in homeostatic T cell proliferation, is one of the
factors responsible for the persistence of CD8 cells in the brain
of SIV-infected macaques (Marcondes et al., 2007). However,
although SIV-infected Meth-treated macaques presented higher
levels of IL15 in the brain, they did not show a higher number
of CD8 T cells in the brain compared to SIV only (Marcondes
et al., 2010). Nevertheless, a higher inﬂammatory inﬁltrate,
characterized by macrophages expressing activation markers
such as CCR5 and high CD11b, was induced by Meth in SIV-
infected brains (Marcondes et al., 2010). In addition, the isolated
macaque mononuclear cells examined in this study were highly
enriched for CD11b+ cells (≥89%). Therefore, we investigated
whether IL15 signaling through IL2RG could potentially act on
innate immune cells such as macrophages, and we also compared
its performance to the performance of other IL2RG-binding
cytokines that were also increased by Meth and/or SIV, IL4 and
IL7. For consistency, here we used THP1 cells, which are from
a stable human macrophage cell line. Human macrophages are
diﬀerent frommicroglia, but serve as a reasonable approximation
for cell culture experiments and to strengthen evidence for
pathways that converge with brain ﬁndings.
Using ﬂow cytometry, we examined whether optimal
physiological concentrations of IL15 and of the other cytokines
that bind to IL2RG, including IL4 and IL7, have the ability to
induce changes in the surface expression of previously described
activation and proliferation markers (Marcondes et al., 2001,
2007, 2008). Importantly, these treatments did not aﬀect the
viability of the cells. For this assay, IFNb was used in parallel
as a positive control, and consistently induced an increase
in activation, as accessed by the expression levels of CD11b,
CCR5, and CD11a by ﬂow cytometry (Figure 3). In forward
versus side scatter plots, the cells were highly homogeneous, and
were gated based on average size, to exclude potential doublets
and debris. The exposure of THP1 macrophages to IL4, IL7,
and IL15 over the course of 48 h increased the expression of
CD11b (ANOVA, excluding IFNγ, p = 0.023; Figures 3A,D),
but did not aﬀect the expression of CCR5 (Figures 3B,E), or
other subset markers such as CX3CR1, CCR2, and CD80 (not
shown). The percentage of cells expressing the activation marker
CD11a high was also increased by IL4, IL7, and IL15 (not
shown, ANOVA, except IFNγ, p = 0.0016). Without treatment,
40.1% (±7.23) of the THP1 macrophages were CD11a high,
and the percentage was increased to 53.75 (±4.15, Bonferroni
p = 0.0001) by IL4, to 50.83 (±5.13, Bonferroni p = 0.03)
by IL7, and to 66.83 (±3.14, Bonferroni p = 0.0001) by IL15.
These cytokines also signiﬁcantly increased the expression of
Ki67 in macrophages (ANOVA, excluding IFNγ p = 0.001;
FIGURE 2 | Immunohistochemistry for detection of IL15 on frontal cortex sections from the brain of a representative (A) SIV-infected animal and of a
(B) SIV-infected Meth-treated animal. Arrows indicate different cell types exhibiting positive staining. Open-head arrows indicate endothelial cells, closed-head
arrows indicate astrocytes, and square-head arrows indicate infiltrating leukocytes. Rectangles indicate magnified regions.
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FIGURE 3 | Expression of surface activation and nuclear proliferation markers in macrophages exposed to IL2RG chain cytokines IL4, IL7, and IL15.
Geometric mean fluorescence of surface (A) CD11b, (B) CCR5, and (C) intracellular Ki67. Results represent the average ± SEM of three experiments performed in
duplicate. Expression histograms of (D) CD11b, (E) CCR5, and (F) Ki-67 show the surface marker distribution in one representative experiment. Isotype controls
were utilized as Negative (Green lines). THP1 cells were treated with 10 U of each cytokine or 1 ng/ml IL4, 1 ng/ml IL7, and 0.5 ng/ml IL15 for 48 h. IFNγ 0.5 ng/ml
was used as a positive control. The cells were harvested and stained for surface CD11b, CCR5 and intracellular Ki67 as described. Results are expressed in
average ± SD of geometric mean fluorescence. ∗p < 0.05 compared to untreated control.
Figures 3C,F), suggesting their ability to increase proliferation
rates in these cells.
Together, this data suggests that the IL2RG binding
cytokines can aﬀect selected activation markers associated
to activation/adhesion as well as proliferation in macrophages,
without aﬀecting subset markers.
IL2RG Cytokines Enhance the Transcription of
M1 and M2 Functional Macrophage Phenotype
Markers In Vitro
In the THP1 cell system, we also examined whether the IL2RG
cytokines can induce a functional phenotypic bias on innate
immune cells. We examined the transcriptional expression of
molecules that characterize M1 (NOS2, TNFα, and IL6) and M2
(Arg1, Mrc1, CD163, TGFβ, Stat6, and IL10) phenotypes.
Regarding M1 functional markers, IL4 signiﬁcantly decreased
the expression of NOS2, TNFα, and IL6 (p = 0.031, p = 0.0006,
p = 0.045, respectively), while IL7 did signiﬁcantly decrease
the expression of TNFα (p = 0.00005) compared to controls
(Figure 4). On the other hand, IL15 signiﬁcantly increased the
expression of NOS2 and IL6 (p = 0.0005 and 0.05, respectively),
but did not aﬀect the expression of TNFα in macrophages in vitro,
compared to no cytokine treatment (Figure 4).
Regarding M2 functional markers, IL4 increased the
expression of CD163 and IL10, but decreased the expression
of TGFβ and Stat6 (Figure 4). IL7 was able to induce the
upregulation of only IL10 (p = 0.0004, Figure 4). On the other
hand, IL15 induced the transcriptional increase of Arg1, CD163,
TGFβ, Stat6, and IL10 (p = 0.02, p = 0.0003, p = 0.000003,
p = 0.00002, p = 0.00009, respectively), but not of Mrc1,
compared to controls.
Overall, IL2RG cytokines were able to aﬀect both M1 and
M2 markers in macrophages. Furthermore, while IL4 largely
decreasedM1 phenotype, and IL7 had a limited ability to enhance
M2 markers, IL15 was able to upregulate both M1 and M2
characteristics.
CD11b-Enriched Brain-Derived Cells from
SIV-Infected Meth-Exposed Animals Exhibit a
Mixed M1/M2 Phenotype in Correlation with
the Elevation of IL15
Isolated brain mononuclear cells from SIV-infected Meth-treated
macaques had a signiﬁcantly higher transcriptional expression
of IL6 (Figure 5A) and Arg1 (Figure 5B), compared to control
animals. The transcription of the M1 marker NOS2 was not
aﬀected by Meth or SIV (Figure 5A). The expression of M2
markers CD163 and Stat6 was increased by Meth and by SIV
alone, as well as by SIV and Meth together (Figure 5B). This
suggests that brain-derived mononuclear cells from Meth alone
or SIV alone exhibit an M2 functional pattern, whereas the
combination of SIV and Meth shows a mixed M1/M2 functional
phenotype.
At the protein level, immunohistochemical studies showed
that there is increase on NOS2-positive cells both with Meth and
with SIV plus Meth (Figures 5E,F, respectively), but not with
SIV alone (Figure 5D), when compared to controls (Figure 5C).
However, the cells that become NOS2-positive do not have
morphological characteristics of microglia or macrophages, but
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FIGURE 4 | IL4, IL7, and IL15 act differentially to modify functional macrophage phenotype in vitro. THP1 cells were treated with 10 U of each cytokine or
1 ng/ml IL4, 1 ng/ml IL7, and 0.5 ng/ml IL15 for 48 h. IFNγ 0.5 ng/ml was used as a control. The cells were harvested and phenotypic markers were accessed by
qPCR. Results represent the average ± SEM of three experiments performed in triplicate. ∗p < 0.05 compared to untreated control.
instead share morphological characteristics with neurons. We
also examined the expression of IL6 in the brain tissue. We
observed that in controls, IL6-positive cells are rare (Figure 5G),
while in SIV-infected macaques IL6-positive cells are abundant,
especially located in layer V of the frontal cortex, in intracellular
vesicular structures (Figure 5H). Such IL6-stained cell structures
can be also found in Meth-treated (Figure 5I), and in SIV plus
Meth. In the latest, endothelial cells also become lightly positive
to IL6 (Figure 5J). Regarding the levels and distribution of
CD163 (Figures 5K–N), we noted that the cells that were CD163-
positive were located predominantly in the perivascular domain.
In controls, CD163-positive cells were rare, but detectable
(Figure 5K). There was an discrete increase in the frequency of
CD163 in SIV-infected (Figure 5L) and in Meth-treated brains
(Figure 5M) when compared to controls. However, animals
that were both SIV-infected and Meth-treated showed a higher
number of CD163-positive cells, which were more abundant
around vessels and were also found in the brain parenchyma
(Figure 5N), suggesting that although transcriptional levels of
CD163 were similar between SIV/Meth, SIV and Meth-alone,
post-transcriptional mechanisms are enhanced by Meth in SIV-
infected brains.
Overall, these results suggest that Meth, in the context of
SIV infection, alters the immune environment in the CNS by
increasing the transcription of IL2RG and of its binding cytokines
IL4, IL7, IL15. Among these cytokines, IL15 showed a stronger in
vitro capacity to increase adhesion molecules, activation markers,
and the proliferation rate on macrophages, as well as to modify
opposing innate immune functional phenotypes.
Discussion
Cytokines utilizing the IL2RG have typically been studied
regarding their ability to interfere with activation, survival,
and homeostasis of T cells (Rubinstein et al., 2008; Sprent
et al., 2008; Surh and Sprent, 2008). Especially in the context
of neuroAIDS, we have reported the involvement of IL15 in
maintaining the presence of activated CD8 T cells chronically in
the CNS (Marcondes et al., 2007). Here, we have shown that, in
a model of Meth abuse in rhesus macaques, IL2RG is the most
signiﬁcantly upregulated gene in innate immune cells isolated
from the brain, regardless of SIV infection. This suggests a role
for this molecule in the neuropathology that is developed byMeth
use. In addition, in the presence of SIV, cytokines that utilize
the IL2RG including IL4, IL7, and IL15 are also upregulated
by Meth compared to SIV only. Nevertheless, in Meth-treated
SIV-infected macaques the number of CD8 or CD4 T cells in
the brain is similar to SIV-only macaques, although a higher
inﬂammatory content, characterized by a higher number of
macrophages, microglia activation and astrogliosis, was observed
(Marcondes et al., 2007). Thus, we investigated the possibility that
these cytokines play a role in the development of inﬂammation
by acting on macrophages and potentially on microglia cells.
We found that, in the THP1 macrophage cell line, IL4, IL7, and
IL15 have the capacity to increase the expression of molecules
such as CD11a and CD11b, which are activation markers and
that play a role in adhesion, opsonization, phagocytosis, and
chemotaxis (Lo et al., 1989). These cytokines did not aﬀect the
expression of HIV-relevant chemokine receptors such as CCR5,
or subset markers, suggesting the selective character of the IL2RG
usage and the potential eﬀect of other receptors of its ligands.
Interestingly, however, IL4, IL7, and IL15 were able to increase
the expression of Ki-67 in macrophage cell lines, suggesting
that these cytokines have the ability to trigger and to increase
the proliferation rate. Meth also enhanced the transcription of
functional markers indicating opposing phenotypes in innate
immune cells, such as IL6 and CD163.
By immunohistochemistry in the macaques’ brains, the
increase in IL6 was clear in all treated groups. On the other
hand, the increase of CD163 was only discrete in Meth or
SIV-infected animals, but highly enhanced in SIV-infected
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FIGURE 5 | Detection of functional M1/M2 phenotypic markers in mononuclear cells isolated from the brain and in brain tissue. Isolated cells and
fixed brain tissue from uninfected controls, or SIV-infected, or Meth-treated, or SIV-infected and Meth-treated macaques were used to detect M1 and M2
functional markers. (A) Transcriptional levels of M1 functional markers NOS2 and IL6. (B) Transcriptional levels of M2 functional markers Arg1, CD163, and
Stat6 in isolated brain-derived mononuclear cells from macaques’ brains. Results represent the average ± SEM of three technical replicates. ∗p ≤ 0.05 in
comparisons shown in lines (one-way ANOVA, followed by Bonferroni’s post hoc test). Immunohistochemistry on paraffin-embedded pre-frontal cortex from
(C,G,K) Uninfected controls, (D,H,L) SIV-infected, (E,I,M) Meth-treated, and (F,J,N) SIV-infected Meth-treated macaques, showing the protein expression and
distribution of (C–F) NOS2, (G–J) IL6 and (K–N) CD163, from one representative animal in each experimental group, at 26x magnification.
animals that were also Meth-treated, compared to controls.
In perspective with transcriptional data from macaques’ brain-
derived mononuclear cells, where there were no diﬀerences in
CD163 levels between SIV-infected, Meth-treated or SIV/Meth
animals, this suggests that Meth may have an action in post-
transcriptional mechanisms, further enhancing the phenotypic
shift. Additional experiments will be necessary using brain-
derived primary cultures to conﬁrm the role of these cytokines
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in driving proliferation and enhancing selective aspects of
the inﬂammatory phenotype, both transcriptionally and at the
protein level.
The IL2RG cytokine system plays a role in determining the
character of the local immune environment, in the brain and
elsewhere. For instance, it has been reported that activation
of macrophages via IL4 can induce their proliferation locally
(Jenkins et al., 2011). In addition, macrophages activated by IL4
exhibit an M2 phenotype (Loke et al., 2002), which produce
immune regulatory factors, such as IL10 and TGFβ1 that
dampen the immune response. In an Alzheimer model, short-
term IL4 expression increases amyloid deposition, likely through
decreased ability of glial cells to scavenge debris (Chakrabarty
et al., 2012). Conversely, IL15 has been suggested to be an
autocrine regulator of macrophage functions, which is able
to induce TNFα and other pro-inﬂammatory markers, such
as iNOS and IFNb (Alleva et al., 1997; Liu et al., 2004).
In addition, IL15 has a role in preserving NK homeostasis
and activity (Ranson et al., 2003a,b), which is in agreement
with our previous ﬁndings of enhanced NK activity in the
brain of Meth-treated SIV-infected macaques (Marcondes et al.,
2010). Whether the functions of IL4 and IL15 in macrophages
depend on signaling through IL2RG or other receptors remains
unclear.
Furthermore, these cytokines can contribute to the
development of CNS pathology through their actions on neurons.
For instance, we have recently reported that IL4 can be an
important component leading to selective loss of dopaminergic
neurons upon usage of IL13Rα1 expressed on DA cells (Morrison
et al., 2012). The increase of IL4 in the brain of Meth-treated
animals, regardless of SIV infection, can therefore oﬀer an
explanation for a high incidence of Parkinson’s disease among
drug users (Thrash et al., 2009).
Cerebral IL15 has also been regarded as a cytokine with
implications in neuropathology and behavior. For instance,
IL15 is correlated to astrogliosis, and promotes the activation
of MAPK and NFkB (Gomez-Nicola et al., 2008a,b, 2010a,b).
Conversely, IL15 has anti-apoptotic and neurotrophic eﬀects, due
to its ability to suppress nitric oxide in neurons (Budagian et al.,
2006), which can be one of the components responsible for its
protective eﬀects in experimental autoimmune encephalomyelitis
(Gomez-Nicola et al., 2010a). In contrast, IL15-producing
astrocytes are a characteristic of demyelinating MS lesions,
potentially contributing to CD8 eﬀector functions (Saikali et al.,
2010). Thus, IL15 can be potentially beneﬁcial, although it has
been associated to neurodegeneration. In LPS models, the pro-
inﬂammatory actions of IL15 may be through IL2RG, which
is highly upregulated in several areas of the brain such as
hypothalamus and striatum, while the increase on IL15RA seems
to be restricted to the hypothalamus (Pan et al., 2013). In EAE,
the upregulation of IL2RG and other IL15-binding receptors is
widespread (Pan et al., 2013).
IL15 seems to have an important positive impact on mood and
memory through IL15RA signaling (Pan et al., 2013). Animals
lacking IL15RA show depressive-like behavior and impaired
memory, even though they show reduced anxiety (Wu et al.,
2011). Interestingly, our data suggests that IL15RA is signiﬁcantly
upregulated by SIV infection. However, the lack of IL2RG does
not show the same eﬀects, although a side-by-side comparison
was never performed (He et al., 2010; Wu et al., 2010a,b). Thus,
IL2RG cytokines can act not only on T cells, but also directly
on innate immune cells, as factors that can contribute to the
alterations of the CNS environment toward inﬂammation and
dysfunction.
Overall, our data suggests that the ability of Meth to increase
IL2RG, and its ligand cytokines in the context of SIV infection,
is an important cellular and biochemical mechanism that could
contribute to aggravating the neuroinﬂammatory scenario in
HIV-infected patients that are drug users, by driving important
phenotypic changes in local innate immune cells.
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